CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)
Phase of Trial: Phase II
Latest Information Update: 24 Jan 2018
At a glance
- Drugs Palbociclib (Primary)
- Indications Chordoma
- Focus Therapeutic Use
- Acronyms NCT-PMO-1601
- 19 Dec 2017 Status changed from not yet recruiting to recruiting.
- 08 Sep 2017 Trial design presented at the 42nd European Society for Medical Oncology Congress.
- 18 Apr 2017 New trial record